Home » Events » 🇬🇧 Harnessing innate immunity in cancer therapy

🇬🇧 Harnessing innate immunity in cancer therapy

08/09/2022 11:00 to 12:00
  • Lecture Series Cancer Research

Speaker

Prof. Eric
Vivier

Abstract

New therapies that promote antitumor immunity have been recently developed. Most of these immunomodulatory approaches have focused on enhancing T-cell responses, either by targeting inhibitory pathways with immune checkpoint inhibitors, or by targeting activating pathways, as with chimeric antigen receptor T cells or bispecific antibodies. Although these therapies have led to unprecedented successes, only a minority of patients with cancer benefit from these treatments, highlighting the need to identify new cells and molecules that could be exploited in the next generation of immunotherapy. Given the crucial role of innate immune responses in immunity, harnessing these responses opens up new possibilities for long-lasting, multilayered tumor control. We will present innovative anti-tumor therapies based on the manipulation of the innate immune system.


Responsible Scientist
Jochen
Klucken

ACCESS THE WEBINAR

Event Number: 2730 403 9040

Event Password: 3ynXKMx49pJ

Supported by:

Share

DATA PRIVACY

Read more about the “Data Protection Notice: processing of personal data in the scope of events’ management”.

Make a donation